0001104659-23-112563.txt : 20231030
0001104659-23-112563.hdr.sgml : 20231030
20231030160853
ACCESSION NUMBER: 0001104659-23-112563
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231026
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Joseph Patrick
CENTRAL INDEX KEY: 0001368711
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37846
FILM NUMBER: 231360285
MAIL ADDRESS:
STREET 1: PETER TSOFLIAS, C/O BLANK ROME LLP
STREET 2: ONE LOGAN SQUARE, FL 9
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001671502
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
BUSINESS ADDRESS:
STREET 1: 23 HATA'AS STREET
CITY: KFAR SABA
STATE: L3
ZIP: 44425
BUSINESS PHONE: 97299741444
MAIL ADDRESS:
STREET 1: 23 HATA'AS STREET
CITY: KFAR SABA
STATE: L3
ZIP: 44425
FORMER COMPANY:
FORMER CONFORMED NAME: Cellect Biotechnology Ltd.
DATE OF NAME CHANGE: 20160721
FORMER COMPANY:
FORMER CONFORMED NAME: Cellect Biomed Ltd.
DATE OF NAME CHANGE: 20160406
4
1
tm2329341-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-26
0
0001671502
Quoin Pharmaceuticals, Ltd.
QNRX
0001368711
Cooper Joseph Patrick
C/O QUOIN PHARMACEUTICALS LTD.
42127 PLEASANT FOREST COURT
ASHBURN
VA
20148
1
0
0
0
0
Share Option (Right to Buy)
5.75
2023-10-26
4
A
0
7652
0
A
2024-10-26
2033-10-26
American Depositary Share
7652
7652
D
The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.
/s/ Joseph Cooper
2023-10-30